Aracea Therapeutics

Diabetes reversed in mice with genetically edited stem cells derived from patients

CRISPR corrects genetic defect so cells can normalize blood sugar Using induced pluripotent stem cells produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes called Wolfram syndrome, researchers transformed the human stem cells into insulin-producing cells and used the gene-editing tool CRISPR-Cas9 to correct a genetic defect that had … Read more

Do brown adipose tissue receptors hold the key to treating obesity and diabetes?

New research suggests that transient receptor channels (TRPs) activated in progenitor cells can help create more According to research published online in The FASEB Journal, scientists have discovered a way to increase the amount of metabolism-boosting brown adipose tissue (BAT) (“good” fat) by employing two receptors on BAT cells as potential therapeutic targets. Both receptors, … Read more

Thermogenic adipocyte generation using human pluripotent stem cells

Brown adipocytes are promising cell targets to counteract obesity thanks to their potential to drain and oxidize circulating glucose and triglycerides. Pluripotent stem cells (PSCs), i.e., embryonic stem cells and induced pluripotent stem cells, help gain insight into the different phases in the development of multiple cell types. Differentiation of human PSCs into thermogenic adipocytes … Read more